$1.030
-0.713 (-69.25%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
FEED Prediction & Forecast by Similar Chart Analysis
Alphio's FEED stock price prediction model matches the current ENvue Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.01 (-1.49%). The 1-week path is $0.98 (-4.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ENvue Medical Inc Stock?
ENvue Medical, Inc. (FEED) is not a good buy right now due to its extremely low price of $1.03, a staggering year-to-date change of -96.50%, and an RSI of 7.252 indicating oversold conditions. The company has also reported a gross margin of -111.30% in Q2 2026, highlighting severe profitability issues. The main risk is its recent performance, with a 5-day change of -75.93%, indicating continued downward pressure on the stock.
FEED stock price ended at $1.03 on Tuesday, after losing -69.25%
ENvue Medical Inc (FEED) last closed at $1.03, losing -69.25%. These facts feed the 1-day and 1-week FEED price prediction above.
Forecast Drivers
ENvue Medical Inc (FEED) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches FEED, ranked by similarity.
Seasonality analysis for FEED
Related articles
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.